US stocks

Investors eagerly await to find out what Chevron will do with an influx of cash after its buyback plans disappointed them in the previous quarter.

Twitter has a big job on its hands as it prepares to release quarterly results, with all the attention on the legal battle with Elon Musk pencilled-in later this year.

The S&P500 closed 2.62% higher overnight, for its best session since June 24, rallying back to the 3950 level it brutally rejected in late June.

This could be the toughest quarter of 2022 and the outlook could also disappoint as the economic outlook continues to deteriorate.

Tesla’s delivery numbers took a temporary hit as disruption in China, supply chain woes and a slow ramp-up at its new factories all weigh on production.

U.S stock markets are on track to lock in their worst first-half performance in decades. The S&P500 is currently down over 15% in the second quarter and on track to lock in an ~20% decline for the first half of the year.

Kellogg Company has announced a division of its plant-based, cereal, and snacking brands into three new companies. It’s a major portfolio split that shot Kellogg’s shares up 8% on the day of the announcement. Learn more about the split and what impacts you can expect to see on the company’s stock.

Despite data from China today that showed the Omicron outbreak appears under control and that Chinese economic data may have bottomed, it's been a disappointing day for U.S equity futures, giving back all of yesterday's gains and more

News reports that Putin has Authorised Special Military Operation in Ukraine’s Donbass has prompted a rapid repricing in risk assets and safe havens alike this afternoon.

Q4 reporting season picks up speed this evening with reports from financial heavyweights JP Morgan, Wells Fargo, Citigroup, and Blackrock, before 114 companies report next week. See below the key themes and trends we'll be monitoring.

The 2021 IPO market saw a record-breaking number of listings and amount of capital raised. Will 2022 follow the trend or has volatility dampened investors’ spirits? See our expectations for the 2022 IPO market, the biggest upcoming listings and a look back at the latest IPOs.

Chubb expands in Asia through deal with Cigna, Tesla moves HQ, Allogene’s cancer drug trial is put on hold, Quidel sees demand for its tests rise, Japan orders more Pfizer vaccines, Ford struggles to source materials, and Oatly is upgraded following a heavy selloff.